These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
473 related items for PubMed ID: 23500524
1. ShRNA targeting Notch1 sensitizes breast cancer stem cell to paclitaxel. Mao J, Song B, Shi Y, Wang B, Fan S, Yu X, Tang J, Li L. Int J Biochem Cell Biol; 2013 Jun; 45(6):1064-73. PubMed ID: 23500524 [Abstract] [Full Text] [Related]
2. The eradication of breast cancer and cancer stem cells using octreotide modified paclitaxel active targeting micelles and salinomycin passive targeting micelles. Zhang Y, Zhang H, Wang X, Wang J, Zhang X, Zhang Q. Biomaterials; 2012 Jan; 33(2):679-91. PubMed ID: 22019123 [Abstract] [Full Text] [Related]
5. The Hedgehog signalling pathway mediates drug response of MCF-7 mammosphere cells in breast cancer patients. He M, Fu Y, Yan Y, Xiao Q, Wu H, Yao W, Zhao H, Zhao L, Jiang Q, Yu Z, Jin F, Mi X, Wang E, Cui Z, Fu L, Chen J, Wei M. Clin Sci (Lond); 2015 Nov; 129(9):809-22. PubMed ID: 26201092 [Abstract] [Full Text] [Related]
6. HES1-mediated inhibition of Notch1 signaling by a Gemini vitamin D analog leads to decreased CD44(+)/CD24(-/low) tumor-initiating subpopulation in basal-like breast cancer. So JY, Wahler J, Das Gupta S, Salerno DM, Maehr H, Uskokovic M, Suh N. J Steroid Biochem Mol Biol; 2015 Apr; 148():111-21. PubMed ID: 25541438 [Abstract] [Full Text] [Related]
7. High mitochondrial mass identifies a sub-population of stem-like cancer cells that are chemo-resistant. Farnie G, Sotgia F, Lisanti MP. Oncotarget; 2015 Oct 13; 6(31):30472-86. PubMed ID: 26421710 [Abstract] [Full Text] [Related]
8. Estrogen receptor α attenuates therapeutic efficacy of paclitaxel on breast xenograft tumors. Chang J, Sui M, Fan W. Breast Cancer Res Treat; 2012 Aug 13; 134(3):969-80. PubMed ID: 22374518 [Abstract] [Full Text] [Related]
9. Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice. Aggarwal BB, Shishodia S, Takada Y, Banerjee S, Newman RA, Bueso-Ramos CE, Price JE. Clin Cancer Res; 2005 Oct 15; 11(20):7490-8. PubMed ID: 16243823 [Abstract] [Full Text] [Related]
11. The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces growth inhibition and enhances taxol-induced cell death in breast cancer. Shi YK, Li ZH, Han XQ, Yi JH, Wang ZH, Hou JL, Feng CR, Fang QH, Wang HH, Zhang PF, Wang FS, Shen J, Wang P. Cancer Chemother Pharmacol; 2010 Nov 15; 66(6):1131-40. PubMed ID: 20838997 [Abstract] [Full Text] [Related]
12. Reversal of multidrug resistance by two nordihydroguaiaretic acid derivatives, M4N and maltose-M3N, and their use in combination with doxorubicin or paclitaxel. Chang CC, Liang YC, Klutz A, Hsu CI, Lin CF, Mold DE, Chou TC, Lee YC, Huang RC. Cancer Chemother Pharmacol; 2006 Nov 15; 58(5):640-53. PubMed ID: 16544145 [Abstract] [Full Text] [Related]
16. The oncolytic herpes simplex virus vector G47∆ effectively targets breast cancer stem cells. Zeng W, Hu P, Wu J, Wang J, Li J, Lei L, Liu R. Oncol Rep; 2013 Mar 15; 29(3):1108-14. PubMed ID: 23292314 [Abstract] [Full Text] [Related]
19. Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB in breast cancer cells and potentiates the growth inhibitory effect of paclitaxel in a breast cancer nude mice model. Kang HJ, Lee SH, Price JE, Kim LS. Breast J; 2009 Mar 15; 15(3):223-9. PubMed ID: 19645775 [Abstract] [Full Text] [Related]
20. Combinatorial TGF-β attenuation with paclitaxel inhibits the epithelial-to-mesenchymal transition and breast cancer stem-like cells. Park SY, Kim MJ, Park SA, Kim JS, Min KN, Kim DK, Lim W, Nam JS, Sheen YY. Oncotarget; 2015 Nov 10; 6(35):37526-43. PubMed ID: 26462028 [Abstract] [Full Text] [Related] Page: [Next] [New Search]